Products from BPS Bioscience require a minimum order value above 400€
Background: It has been reported that BIBR 1532 inhibited the reverse transcriptase of telomerase, hTERT, and shortened the length of the telomerase to suppress human cancer cell proliferation. In pre-B acute lymphoblastic leukemia cells, BIBR1532 suppressed c-Myc and hTERT expression in a concentration-dependent manner to inhibit telomerase activity, and high doses of BIBR1532 could induce apoptosis by elevating p73, Bax/Bcl-2 and caspase-3 activation. In NB4 leukemic cells, combined treatments with BIBR 1532 and arsenic trioxide suppressed cell proliferative capacity and inhibited telomerase activity probably via transcriptional suppression of c-Myc and hTERT.
CAS Number: 321674-73-1
Description: BIBR 1532 is a novel, specific telomerase inhibitor with IC50 = 93 nM.
Solubility: Soluble in DMSO
Storage Stability: Store at or below -20°C. Solid form is stable at least 12 months from date of receipt, when stored as directed. Do not store aqueous solutions for more than one day.
Target: Telomerase
Biosafety Level: Not applicable (BSL-1)
References: 1. Damm, K., et al. EMBO J. 2001, 20, 6958?6968.
2. Bashash D., et al. Leuk Lymphoma. 2013 Mar;54[4]:561-8.
3. Bashash D., et al. Anticancer Agents Med Chem. 2013 Sep;13(7):1115-25.
English
Deutsch
